Akoya has developed the CODEX Technology to provide a comprehensive solution for spatially-resolved, highly multiplexed biomarker analysis.
Developing PRDM Gene and Protein Modulation Agents as Anti-Cancer Products
Firalis is a biotechnology company with a mission to create novel values via biomarker discovery, development and regulatory qualification that ultimately leads to biomarker-based diagnostics.
Personalized management of sepsis
The mission of IROA Technologies is to simplify our customer's metabolomics research.
Founded in 1995, Meso Scale Discovery (MSD) is a leader in the development, manufacture, and commercialization of innovative assays and instruments for the measurement of molecules in biological ...
Myriad RBM develops and sells immunoassays to measure biomarkers in blood.
NeuroPointDX, through its compound safety screening division Stemina Biomarker Discovery, has developed the leading metabolomics platform for ...
OrigiMed is a medical science and technology company that is focused on identifing cancer specific molecular markers and genomic features to guide targeted or immuno-therapy, ultimately aim to ...
Biomarker Identification, Drugs
Biomarker testing services
Biomarker Discovery & Lipidomic Services